ACTA FAC MED NAISS 2024;41(2):272-278 |
Case report
UDC:
Running title: Co-Infection with SARS-CoV-2
A
Co-Infection of
Primary Varicella and COVID-19:
Irfan Ćorović1,2,
Emina Ćorović Ličina3, Bojana Simović Marković1, Selma
Habibović4,
1University of Kragujevac, Faculty of Medical
Sciences, Center for Molecular Medicine and Stem Cell Research, Kragujevac,
Serbia
Introduction. Primary varicella usually occurs in childhood and is generally
self-limiting. In adults and immunocompromised individuals, it can have a more
serious course. Obesity is one of the risk factors for a severe COVID-19
infection that can lead to immunosuppression among other systemic complications.
This case report aims to present a rare co-infection of varicella-zoster virus
and SARS-CoV-2 in an adult, as well as to evaluate the impact of this
co-infection on the progression and severity of both diseases in order to
highlight the significance of antiviral therapy in treating both infections.
Case report. We report a case of a 34-year-old obese woman with varicella-zoster
virus and SARS-CoV-2 co-infection who was successfully treated with oral
acyclovir and nirmatrelvir-ritonavir without developing significant
complications.
Conclusion. Currently, there is not enough evidence to claim that co-infection
with varicella-zoster virus and SARS-CoV-2 increases the chances of a more
severe form of either of these infections. With effective antiviral therapy, it
is possible to significantly reduce the chances of developing more severe forms
of both infections, which physicians need to be aware of in case they come
across it and respond promptly.
Keywords: COVID-19, SARS-CoV-2, primary
varicella, varicella-zoster virus
Corresponding author:
Irfan Ćorović
e-mail: ira.corovic@gmail.com